載入...
A pharmacological modification of pain and epithelial healing in contemporary transepithelial all-surface laser ablation (ASLA)
PURPOSE: We report our experience with the use of the matrix regenerating agent (RGTA) Cacicol(®) after reverse transepithelial all-surface laser ablation (ASLA)-SCHWIND to assess the safety, efficacy, pain, and epithelial healing. METHODS: Forty eyes of 20 myopic patients were prospectively recruit...
Na minha lista:
| 發表在: | Clin Ophthalmol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404873/ https://ncbi.nlm.nih.gov/pubmed/25931809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S81061 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|